 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Max Planck Team Links miR-802 to Insulin Resistance, Type II Diabetes
February 07, 2013
Max Planck Team Links miR-802 to Insulin Resistance, Type II Diabetes
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Intermountain Team Reports on miRNAs as Biomarkers of Imminent Heart Attack
March 29, 2012 / Gene Silencing News - Researchers ID Mouse MicroRNAs Mediating Insulin Sensitivity
June 8, 2011 / GenomeWeb Daily News - UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News - NIH Awards $400K to Fund Three microRNA Research Grants in May
May 23, 2013 / Gene Silencing News - MiRagen Hits First Milestone in Servier microRNA Drug Partnership
May 23, 2013 / Gene Silencing News